The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Change

19 May 2023 18:04

RNS Number : 1004A
WANdisco Plc
19 May 2023
 

19 May 2023

WANdisco plc 

 

("WANdisco" or the "Company") 

 

Board Change 

 

WANdisco (LSE: WAND), the data activation platform, announces that non-executive director William Grant Dollens will be stepping down from the Board of Directors, effective from 19 May 2023.

 

Mr Dollens, appointed on 9 October 2016, has been a non-executive director for over six years. He has now agreed with the Board that having served a six-year term as originally envisaged at the time of his appointment, now is an appropriate time to step down as the Company embarks upon the next phase of development. During his tenure, Mr Dollens has provided invaluable input to Board discussions and his contribution is greatly appreciated. Recently Mr Dollens has been instrumental in securing the appointment of interim Chair Ken Lever, interim CEO Stephen Kelly, and interim CFO Ijoma Maluza.

Mr Dollens will continue to be available to the Board on an ad hoc basis to provide it with the benefit of his knowledge and experience of the Company and its technology.

Mr Dollens commented:

"I have been a non-executive director of WANdisco for more than the originally envisaged two three- year terms and have been a champion of its potential and its technology from the outset. I have worked hard to help put the Company in a position to continue forward with a strong leadership team. I believe strongly in WANdisco's technology and believe that Ken can lead the recovery and rebuilding process well. With Stephen and Ijoma now on board too, I believe the Company has a great opportunity to build a high-quality, global technology business.

I would like to thank the Board as a whole for their hard work and I want to express my gratitude to the WANdisco colleagues who I believe are working incredibly hard through a challenging period."

Ken Lever, Chairman of WANdisco plc, added:

"Grant has been an invaluable member of the Board and has been of particular help to me since I joined it, giving generously of his time to brief me on the background, technology, and opportunities open to WANdisco. I look forward to continuing a constructive dialogue with him as the Board continues to focus on advancing the fundraising and other workstreams that are designed to lift the current suspension of WANdisco's shares and position the Company for long term success."

 

For further information, please contact:

 

FTI Consulting

 

+44 (0)20 3727 1137

Rob Mindell / Kwaku Aning / Matt Dixon

 

 

Stifel (Nomad and Joint Broker)

 

+44 (0)20 7710 7600

Fred Walsh / Richard Short / Tom Marsh

 

 

Liberum (Joint Broker)

 

Max Jones / William Hall

 

+44 (0)20 3100 2000

 

 

About WANdisco

WANdisco is the data activation platform for accelerating digital transformation at scale. WANdisco makes infinite data actionable across clouds and enterprises in real time. WANdisco customers unleash the business value of the cloud with zero downtime, data loss, or disruption to fuel AI and machine learning, create new services, and transform businesses. For more information about WANdisco, visit  www.wandisco.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADKLFFXELBBBF
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.